0001213900-13-004938.txt : 20130905 0001213900-13-004938.hdr.sgml : 20130905 20130905125740 ACCESSION NUMBER: 0001213900-13-004938 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130830 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20130905 DATE AS OF CHANGE: 20130905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Joway Health Industries Group Inc CENTRAL INDEX KEY: 0001263364 STANDARD INDUSTRIAL CLASSIFICATION: [9995] IRS NUMBER: 980221494 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-108715 FILM NUMBER: 131079845 BUSINESS ADDRESS: STREET 1: NO 2 BAOWANG DR STREET 2: BAODI ECONOMIC DEVELOPMENT ZONE CITY: TIANJIN, PRC STATE: F4 ZIP: 300180 BUSINESS PHONE: 862258896888 MAIL ADDRESS: STREET 1: NO 2 BAOWANG DR STREET 2: BAODI ECONOMIC DEVELOPMENT ZONE CITY: TIANJIN, PRC STATE: F4 ZIP: 300180 FORMER COMPANY: FORMER CONFORMED NAME: G2 VENTURES INC DATE OF NAME CHANGE: 20030911 8-K 1 f8k083013_jowayhealth.htm CURRENT REPORT f8k083013_joway.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of Earliest event Reported): August 30, 2013
 
Joway Health Industries Group Inc.
(Exact name of registrant as specified in its charter)
 

         
Nevada
 
333-108715
 
98-0221494
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
No. 2 Baowang Road
Baodi Economic Development Zone
Tianjin, PRC 300180
(Address of principal executive offices)
 
Registrant’s telephone number, including area code: 86-22-58896888
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
 


 
 

 
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On August 30, 2013, Socorro Quintero and Shepherd G. Pryor IV resigned as directors of Joway Health Industries Group Inc. (“Joway”).  In addition to their service on Joway’s Board of Directors, Ms. Quintero and Mr. Pryor both served as members of the Board’s Audit Committee. Ms. Quintero and Mr. Pryor’s resignation, which was effective immediately, is not the result of any disagreement with Joway on any matter relating to its operations, policies or practices.

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: September 3, 2013
 
  Joway Health Industries Group Inc.
  (Registrant)
     
 
By:  
/s/ Jinghe Zhang
   
(Signature)
     
   
President and Chief Executive Officer
   
(Title)